Foghorn Therapeutics Inc. announced the election of B. Lynne Parshall, Esq., to its Board of Directors and appointment as Chair of the Audit Committee. Ms. Parshall brings nearly three decades of experience in finance and operations in the biotechnology industry. She currently serves as the Senior Strategic Advisor for Ionis Pharmaceuticals.

At Ionis, as chief financial officer and chief operating officer, Ms. Parshall was responsible for driving the strategy that led to Ionis' growth into a multibillion-dollar company. Ms. Parshall currently serves on the Boards of Directors of Ionis, Cytokinetics, Repertoire Immune Medicines, and Ring Therapeutics. Ms. Parshall started her career by practicing law at Cooley LLP and remains a member of the American and California Bar Associations.

Ms. Parshall holds a B.A. from Harvard University and a J.D. from Stanford Law School.